Seizure management protocol spans everything from the first seconds of a witnessed seizure through emergency drug treatment, intensive-care escalation, and long-term planning to prevent the next one. The core principle running through every stage is time: the longer a seizure goes on, the harder it becomes to stop and the more likely it is to cause lasting harm. What bystanders, paramedics, emergency physicians, and neurologists do at each step follows an increasingly aggressive ladder of interventions, and understanding where one rung ends and the next begins can genuinely change outcomes.
What Bystanders Should Do in the First Minutes
The initial response to a witnessed seizure is about safety, not treatment. Effective seizure first aid training consistently emphasizes a short list of priorities: keep the person safe, do not restrain them, protect the airway, avoid putting anything in the mouth, note the time the seizure started, and call for professional help if it does not stop on its own.1PubMed Central. Seizure first aid in the community: current situation, suggestions, and the role of the general practitioner in seizure management In practical terms, that means easing the person to the floor, moving furniture or sharp objects out of range, and loosening anything tight around the neck.
One area where guidance has recently gotten more nuanced is the recovery position. Turning someone onto their side after the convulsions stop is widely taught and generally sensible for protecting the airway. But a scoping review published in 2025 found no evidence that rolling a person onto their side during active convulsions reduces aspiration or breathing problems. Worse, forcing a lateral position while someone is still seizing can cause shoulder dislocations serious enough to require surgery, and it can make it harder to recognize cardiac arrest if the heart stops.2PubMed. Recovery position for generalised seizures: A focused scoping review of guidelines and original research The practical takeaway: once the shaking stops, gently roll the person onto their side. While convulsions are still happening, focus on keeping the area safe and wait.
When a Seizure Becomes Status Epilepticus
Most seizures stop on their own within one to two minutes. The critical threshold is five minutes for generalized tonic-clonic seizures (the dramatic, full-body convulsive type). After five minutes of continuous seizing, the International League Against Epilepsy classifies the event as status epilepticus, a medical emergency with rising risk of brain injury the longer it goes. For focal seizures with impaired awareness, that threshold extends to ten minutes, and for absence seizures it sits at ten to fifteen minutes.3Medicina ClÃnica (English Edition). Treatment administration during a seizure in home-settings: Time to treat (TT) These time points are not arbitrary; they reflect the point at which self-termination becomes unlikely and pharmacological intervention becomes necessary.
For families managing a child or adult with known epilepsy at home, the five-minute mark is the signal to administer a prescribed rescue medication rather than continue waiting. Every protocol hinges on this clock, and anything that delays treatment, whether it is fumbling with a medication, uncertainty about the plan, or hesitation to act, shifts outcomes for the worse.
First-Line Medications and How They Are Given
Benzodiazepines are the universal first-line treatment for prolonged seizures and status epilepticus. In the hospital, intravenous lorazepam has long been standard. But the landmark RAMPART trial changed prehospital practice by demonstrating that intramuscular midazolam is not just equivalent but actually superior in real-world conditions. Among patients treated by paramedics, seizures had stopped by the time they reached the emergency department in about 73% of those given intramuscular midazolam, compared with roughly 63% of those given intravenous lorazepam.4PubMed Central. Intramuscular versus intravenous therapy for prehospital status epilepticus The reason is simple: starting an IV line on someone actively convulsing takes time, and intramuscular injection can be given almost immediately.
Outside the hospital, midazolam can also be delivered through the nose or inside the cheek, which matters enormously for home use. A randomized trial comparing intranasal, buccal, and intramuscular midazolam in children found no significant difference in effectiveness among the three routes, though caregivers reported the highest satisfaction with the intranasal option because it is the easiest to give during a seizure.5Pediatric Neurology. Intranasal Versus Buccal Versus Intramuscular Midazolam for the Home and Emergency Treatment of Acute Seizures in Pediatric Patients: A Randomized Controlled Trial In one study of children given intranasal midazolam at home, seizures stopped in about 72% of cases, with a median time to cessation of around two and a half minutes.6PubMed. Impact of prescribing intranasal midazolam as rescue medication for domiciliary management of acute seizure among children with epilepsy
The practical implication for families is clear: having an easy-to-use rescue medication prescribed and readily accessible, with caregivers trained in how and when to give it, is one of the most impactful things you can do. A benzodiazepine given at five minutes beats a benzodiazepine given at fifteen, regardless of the route.
Second-Line Treatment When Benzodiazepines Are Not Enough
When a seizure continues despite one or two doses of a benzodiazepine, the protocol escalates to a second-line anti-seizure medication. For years the go-to was phenytoin (or its prodrug fosphenytoin), but that changed with the publication of the ESETT trial, a large randomized study comparing levetiracetam, fosphenytoin, and valproate for established status epilepticus. The results were striking in their evenness: seizures stopped and consciousness improved within sixty minutes in about 47% of the levetiracetam group, 45% of the fosphenytoin group, and 46% of the valproate group, with no statistically meaningful differences among them.7PubMed Central. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
An age-stratified analysis of the same trial confirmed the pattern across children, adults, and older adults, with none of the three drugs showing clear superiority in any age group.8The Lancet. Randomised comparison of levetiracetam, fosphenytoin, and valproate for established status epilepticus: secondary and subgroup analyses of the Established Status Epilepticus Treatment Trial (ESETT) In children specifically, the EcLiPSE trial found that levetiracetam stopped convulsive status epilepticus in 70% of cases compared with 64% for phenytoin, though the difference did not reach statistical significance.9The Lancet. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial
Because all three drugs perform similarly, the choice often comes down to safety profile and ease of use. Fosphenytoin requires cardiac monitoring during infusion and carries a risk of serious arrhythmias. Levetiracetam and valproate are faster to administer and have fewer dangerous side effects, which is why many current pediatric and adult protocols now prefer them.10PubMed Central. Optimal Management of Status Epilepticus in Children in the Emergency Setting: A Review of Recent Advances A real-world audit found that about 28% of status epilepticus cases progress to needing second-line treatment, and levetiracetam was the most commonly used agent, ahead of phenytoin.11ScienceDirect. Early and established status epilepticus: The impact of timing of intervention, treatment escalation and dosing on outcome
Refractory and Super-Refractory Status Epilepticus
When seizures persist despite both a benzodiazepine and a second-line agent, the condition is classified as refractory status epilepticus and the patient typically requires intensive care. Treatment at this stage involves continuous intravenous anesthetic drugs, most often propofol or midazolam infusions, with the goal of suppressing seizure activity on EEG. Outcomes are sobering: favorable results were observed in only about 25% of patients treated with propofol and 21% of those treated with midazolam in one review.12Journal of Neurocritical Care. Management strategies for refractory status epilepticus
Timing matters even within this late stage. A study of patients with refractory status epilepticus found that starting continuous anesthetic infusions within the first 48 hours was independently associated with roughly three times the likelihood of a good outcome compared with later initiation, shorter duration of the refractory phase, and a lower chance of needing the most aggressive suppression strategies.13PubMed Central. Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus
When seizures continue for 24 hours or more despite anesthetic coma, the situation is termed super-refractory status epilepticus, and ketamine has emerged as the most studied add-on therapy. Ketamine works through a different brain receptor than the standard drugs, which is relevant because the receptors targeted by benzodiazepines and similar medications become less responsive during prolonged seizures. A systematic review found seizure resolution rates ranging from roughly 53% to 91% across larger studies, with early use associated with better outcomes.14PubMed Central. Use of ketamine in Super Refractory Status Epilepticus: a systematic review Another study reported that seizure burden dropped by at least half within 24 hours of starting ketamine in about 81% of patients, with complete cessation in 63%.15PubMed Central. Ketamine to treat super-refractory status epilepticus The drug also appears to have a favorable safety profile relative to other anesthetics at this stage, with lower blood-pressure-support requirements.16PubMed Central. The efficacy and safety of ketamine in the treatment of super-refractory status epilepticus: a systematic review
The Role of EEG and Brain Imaging
Not all seizures are obvious. Non-convulsive status epilepticus, where the brain is seizing but the body shows only altered consciousness or subtle twitching, is notoriously easy to miss without an EEG. In one study at an emergency intensive care unit, simplified continuous EEG monitoring detected non-convulsive status epilepticus in about 30% of patients who had unexplained altered mental status.17PubMed Central. Clinical characteristics of non-convulsive status epilepticus diagnosed by simplified continuous electroencephalogram monitoring at an emergency intensive care unit A consensus panel of neurophysiologists recommends continuous EEG for any critically ill patient with suspected non-convulsive seizures and for monitoring whether treatment is actually working in known status epilepticus.18PubMed Central. Consensus statement on continuous EEG in critically ill adults and children, part I: indications
Brain imaging serves a different purpose: identifying the cause. For an adult presenting with a first seizure in an emergency setting, a CT scan without contrast is the recommended initial step to rule out conditions that need urgent intervention, such as bleeding or a large mass.19PubMed. Reassessment: neuroimaging in the emergency patient presenting with seizure (an evidence-based review) But CT misses a lot. Among patients whose CT was normal, MRI subsequently identified an epilepsy-causing lesion in about 12%, and those patients had a higher risk of future seizures.20PubMed Central. Neuroimaging of first-ever seizure: Contribution of MRI if CT is normal That is why guidelines recommend MRI as the follow-up for anyone whose initial CT does not explain the seizure, or as the first-line study in non-emergency settings where there is no immediate threat to rule out.21PubMed. Imaging Evaluation of the Adult Presenting With New-Onset Seizure
Seizures in Pregnancy
Pregnancy introduces a unique seizure scenario: eclampsia, where seizures occur in the setting of dangerously high blood pressure, usually in the third trimester or shortly after delivery. The drug of choice here is not a benzodiazepine but magnesium sulfate, and the evidence behind this is among the strongest in all of seizure management. A Cochrane review of six trials found that magnesium sulfate reduced maternal death compared with diazepam, with a relative risk of about 0.59, and cut the risk of further seizures by more than half.22Cochrane Database of Systematic Reviews. Magnesium sulphate versus diazepam for eclampsia In a head-to-head trial against phenytoin for preventing eclampsia in women with severe pre-eclampsia, not a single woman in the magnesium group developed eclamptic convulsions, compared with ten out of roughly 1,100 women in the phenytoin group.23PubMed. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia
Magnesium sulfate is not an anti-seizure drug in the traditional sense. It works through mechanisms related to blood vessel relaxation and blocking excitatory brain receptors, and it has minimal anti-seizure activity outside the eclampsia context. You would not use it for epilepsy-related status epilepticus. But for eclamptic seizures, it is unambiguously the correct first-line agent, and using anything else puts the patient at greater risk.
What Happens After the Seizure Stops
The post-ictal phase, the period of confusion and drowsiness after a seizure ends, is not just a waiting room. It is a diagnostic window. Blood tests drawn soon after a seizure can reveal underlying metabolic problems, infections, endocrine disorders, or toxic exposures that triggered the event.24PubMed. The role of postictal laboratory blood analyses in the diagnosis and prognosis of seizures Low blood sugar, low sodium, kidney failure, and drug or alcohol toxicity are all identifiable with straightforward labs and all require different management than epilepsy.
Clinically, the post-ictal state itself can range from mild grogginess lasting minutes to prolonged confusion or agitation lasting hours. Medical teams monitor for recurrence of seizures, ensure the airway remains clear, and manage any injuries sustained during the event. For someone whose seizures are new, this is also when the workup for a cause begins in earnest, including EEG and imaging as described above.
Seizure Action Plans and Why They Matter
For people living with epilepsy, a written seizure action plan functions much like an asthma action plan: it spells out what medication to give, when to give it, when to call emergency services, and what information to relay to the paramedics. These documents are designed to reduce hesitation and errors during a high-stress event. Evidence suggests that having a seizure action plan in place improves clinical outcomes and reduces missed clinic appointments, which reflects better overall engagement with care.25PubMed. Written seizure action plans for adult patients with epilepsy: Distilling insights from emergency action plans for other chronic conditions A randomized trial in children with epilepsy found that families given a seizure action plan were significantly less likely to miss follow-up appointments than those receiving standard care.26PubMed. Seizure Action Plans for Pediatric Patients With Epilepsy: A Randomized Controlled Trial
A good seizure action plan should include the person’s seizure type, their usual seizure duration, the name and dose of any prescribed rescue medication, step-by-step instructions for a bystander, and clear criteria for calling an ambulance (usually: seizure lasts more than five minutes, the person is injured, the person does not wake up, or it is a first seizure). Plans work best when they are reviewed at every neurology visit and shared with schools, workplaces, and family members.
Reducing the Risk of SUDEP
Sudden unexpected death in epilepsy, or SUDEP, is the leading cause of epilepsy-related death. It occurs most often during or shortly after a seizure, especially a nighttime convulsive seizure when no one is present. The strongest modifiable risk factor, based on case-control data, appears to be nocturnal supervision. Two case-control studies reported large protective effects for overnight monitoring: one found an odds ratio of 0.34, and the other an even more striking 0.08, meaning the risk was dramatically lower when someone was present or a monitoring device was in use.27Cochrane Database of Systematic Reviews. Interventions for preventing Sudden Unexpected Death in Epilepsy (SUDEP) A study across residential epilepsy care centers reinforced this: the center with the lowest level of nocturnal supervision had the highest SUDEP rate.28PubMed. Nocturnal supervision and SUDEP risk at different epilepsy care settings
In practice, this has led to wider adoption of monitoring devices, especially for children. A recent study found that about 46% of pediatric epilepsy patients used some form of monitoring device, with nocturnal monitoring most common in children under four.29PubMed Central. Sudden unexpected death in epilepsy: Risk management of pediatric patients with epilepsy Options range from simple audio monitors and bed-motion sensors to more sophisticated wearable devices that detect rhythmic movements or heart-rate changes. None of these devices prevents SUDEP directly; the value lies in alerting a caregiver who can check on the person, reposition them, or call for help.
Device-Based and Emerging Interventions
Vagus nerve stimulation (VNS) is an implanted device that sends mild electrical pulses to the brain through the vagus nerve. Beyond its role in reducing overall seizure frequency over time, it has an on-demand function: swiping a handheld magnet over the implanted generator delivers an extra burst of stimulation intended to abort or shorten a seizure in progress. A review of 20 studies covering over 850 patients found that about 45% of users reported benefit from the magnet feature, with seizure cessation claimed in about 28% of activations. Others reported shorter seizures or a less severe post-ictal phase even when the seizure was not fully stopped.30PubMed. Vagus nerve stimulation magnet activation for seizures: a critical review
Research is also pushing toward closed-loop systems that detect a seizure and respond automatically. One experimental approach combines a wearable EEG sensor with a soft implantable drug delivery device that releases medication subcutaneously when seizure activity is detected. In animal experiments, this system reduced brain damage and improved survival rates by eliminating the delay between seizure onset and treatment.31PubMed Central. Soft implantable drug delivery device integrated wirelessly with wearable devices to treat fatal seizures The technology is still early-stage and far from clinical use in humans, but it illustrates the direction the field is heading: removing human reaction time from the equation entirely, so that rescue medication arrives within seconds of a seizure starting rather than minutes.